Ondas Reported Record Revenue and a Record Loss in the Same Quarter. The Shorts See a Funding Treadmill.

Ondas Holdings (ONDS) sells what the market is paying up for right now: autonomous drones, counter-drone systems, and defense AI for government buyers. On paper it looks like everything the moment wants. Second-quarter revenue reached $83.8 million, a record, up more than thirteen-fold from a year earlier, and management raised its full-year guidance again. And this week — after a $6.9 million counter-drone contract in Australia popped the stock 5.4% to about $7.40 — roughly 41% of the public float was still sold short.

The story works until you set two numbers side by side. In the same three months that Ondas booked $83.8 million of revenue, it recorded a net loss of $89.7 million. The company lost more money in the quarter than it earned in the entire quarter. That is not a normal gap between a growth story and a bottom line. It is a whole quarter of revenue, spent and then some, before the loss line even starts.

Let me be precise about what heavy short interest is and isn't. A short is a bet that a stock falls. Forty-one percent of the float short is not an accusation of fraud, and the number alone proves nothing. It is, however, a crowd of investors betting on a specific mechanism: that a company can keep growing revenue while the cash for that growth comes from newly printed shares, and that the promised profitability keeps getting pushed further out.

The thirteen-fold number is mostly a shopping list

The $83.8 million headline says "thirteen-fold growth." Read the footnote underneath and the real magnitude changes. Ondas grew by buying.

In early August the company closed its largest acquisition, autonomous-aircraft maker DZYNE Technologies, for $875.8 million — about $200 million in cash and roughly $675 million in new Ondas stock. The same quarter closed Cyberhawk as well, with around $325 million in cash going out the door to pay for both deals. The revenue those companies contribute is real, but it did not come from Ondas selling more last year; it came from Ondas writing checks and issuing shares this year.

Management's own cleaner gauge says as much. On a pro forma, same-portfolio basis — comparing the same businesses a year ago and today — second-quarter revenue grew 85% year over year. That is still a strong number. But it is 85%, not 1,300%. The thirteen-fold figure is largely the story of what Ondas bought, not what it organically grew.

The cash to buy came from a billion-dollar share sale

None of this is free, and the funding has a specific address. In January, Ondas priced a $1 billion stock-and-warrant sale. It ended June with $1.4 billion in cash, cash equivalents, restricted cash and short-term investments. Management calls the balance sheet a competitive weapon, and in the abstract it is — a $1.4 billion treasury is real.

But trace where that cash came from and the qualification appears. It came from selling roughly a billion dollars of new shares into the market, then issuing hundreds of millions more in stock to pay for DZYNE. Every raise and every stock-financed deal adds shares that split the same economic pie into thinner slices. This is the exact thing the short sellers are selling: the value that flows to new investors as dilution while they wait for the growth to pay.

Even the clean numbers show spending that exceeds the record sales

The $89.7 million loss is inflated by charges that are inside but not cash — stock-based compensation, changes in the fair value of contingent consideration, and amortization made up about $105.8 million of the quarter's $199.1 million of operating expenses.

Strip those out and the cash picture is still the problem. Management's own adjusted cash operating expense came to $93.3 million in the quarter, against $83.8 million of revenue — cash spending still exceeded the record top line. Gross margin was a healthy 43.1% on a GAAP basis, or 50.4% adjusted. The adjusted EBITDA loss widened to $50.6 million, from $5.8 million a year earlier. Management frames the widening as a "front-loading of expenses" needed to support the revenue expansion it expects in the second half — and it has pulled forward operating-platform profitability to the fourth quarter of 2026, with company-wide adjusted EBITDA profitability now expected in the fourth quarter of 2027.

Set that against the valuation and the bet becomes legible. Ondas carries a market value of roughly $4 billion against a raised full-year revenue target of $525–550 million — near eight times forward sales, for a company that does not expect to stop losing money at the total-company level for more than a year. Backlog stood at about $757 million on a pro forma basis, and the company booked $175 million of new orders in the second quarter alone, so the underlying demand is not fiction. The question is whether that demand ever reaches cash profits faster than the share count grows.

What the shorts are really selling

Nothing in the filings yet supports the melodramatic version of this story — that the revenue, the contracts, or the backlog are invented. The red flags here are dilution and cash burn, not fabrication, and treating them as fraud would be the same error as treating a clean headline as proof of health.

What the shorts are selling is closer to an arithmetic forecast. If Ondas must keep issuing stock to fund acquisitions and cash operating losses, then even a company with genuinely multiplying revenue can hand its shareholders a flat or falling price per share. One bear described the setup as "dead money": improving fundamentals, but a dilution overhang and rising short interest that keep the price from reflecting the growth.

That leaves the shareholder invoice out in the open, and it comes in three versions. In the resolved case, the fourth-quarter profitability arrives roughly as promised, the backlog converts, and the dilution slows as the cash burn shrinks — the early investors who took dilution get paid for the growth. In the persistent-but-lawful case, revenue keeps climbing through more acquisitions and more raises, the profit milestone keeps sliding, and every new share sale quietly transfers value from existing holders to whoever funds the next step; the story is true and the stock still goes nowhere. In the materially-misstated case, the revenue or the backlog would have to be fabricated, and nothing in the current record shows that — the evidence stands at the "unusual and worth watching" level, not the "proven wrong" level.

The next settling event, then, is not a headline about short interest. It is the fourth quarter of 2026 — whether the promised operating profit actually shows up, whether the cash balance stops shrinking as fast as the share count grows, and whether the company can let the acquisition machine coast on its own cash flow instead of the next offering. The clue is already on the page. The dollar that decides it will appear in the cash-flow statement, and soon.